Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 6:26 pm Sale | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | Rock Springs Capital Management LP | 0 0.000% | -3,041,559 (Position Closed) | View |
| 2021-05-17 4:34 pm Sale | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,285,161 (Position Closed) | View |
| 2021-03-15 06:33 am Purchase | 13D | FIVE PRIME THERAPEUTICS INC. FPRX | Magnetar Financial LLC | 2,443,768 5.320% | 2,443,768 (New Position) | View |
| 2021-03-08 4:54 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 6,338,678 13.800% | 3,200,000 (+101.95%) | View |
| 2021-03-01 5:00 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | Rock Springs Capital Management LP | 3,041,559 6.930% | 3,041,559 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | RA CAPITAL MANAGEMENT L.P. | 4,285,161 9.800% | 4,285,161 (New Position) | View |
| 2021-02-16 10:26 am Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | RTW INVESTMENTS LP | 2,515,788 5.730% | 2,515,788 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | BlackRock Inc. BLK | 2,959,031 6.700% | 833,854 (+39.24%) | View |
| 2021-02-01 5:19 pm Purchase | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 3,138,678 7.200% | 1,875,000 (+148.38%) | View |
| 2020-12-08 4:56 pm Sale | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | BlackRock Inc. BLK | 2,125,177 4.800% | -410,642 (-16.19%) | View |
| 2020-11-13 5:27 pm Sale | 13D | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 1,263,678 3.300% | -7,100,675 (-84.89%) | View |
| 2020-10-08 5:26 pm Purchase | 13D | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 8,364,353 22.800% | 581,352 (+7.47%) | View |
| 2020-02-14 4:20 pm Sale | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | GREAT POINT PARTNERS LLC | 0 0.000% | -2,398,409 (Position Closed) | View |
| 2020-02-05 11:45 am Sale | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | BlackRock Inc. BLK | 2,535,819 7.000% | -504,096 (-16.58%) | View |
| 2019-12-26 5:56 pm Purchase | 13D | FIVE PRIME THERAPEUTICS INC. FPRX | BIOTECHNOLOGY VALUE FUND L P | 7,783,001 21.400% | 1,815,882 (+30.43%) | View |
| 2019-12-09 09:49 am Sale | 13G | FIVE PRIME THERAPEUTICS INC. FPRX | WELLINGTON MANAGEMENT GROUP LLP | 1,280,750 3.520% | -2,740,074 (-68.15%) | View |